In that setting, we observed ultraviolet light (photo-)therapy, second-line treatment for human AD, to be MR1- and FA-dependent and mediate its therapeutic effect through the 6-FP-mediated blockade of MR1, reducing its ability to present of 5-OP-RU to MAIT cells. The gene discussed is MR1; the disease is Alzheimer disease.